171 related articles for article (PubMed ID: 26082241)
1. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.
Dezorella N; Kay S; Baron S; Shapiro M; Porat Z; Deutsch V; Herishanu Y; Katz BZ
Cytometry B Clin Cytom; 2016 May; 90(3):257-66. PubMed ID: 26082241
[TBL] [Abstract][Full Text] [Related]
2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
3. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
4. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
[TBL] [Abstract][Full Text] [Related]
5. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
6. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Lymphoproliferative Disorders with More Than One Aberrant Cell Population as Detected by 10-Color Flow Cytometry.
Mahdi T; Rajab A; Padmore R; Porwit A
Cytometry B Clin Cytom; 2018 Mar; 94(2):230-238. PubMed ID: 27438095
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of the ClearLLab 10C B cell tube.
Espasa A; Torrents S; Morales-Indiano C; Rico LG; Bardina J; Ancochea A; Bistué-Rovira À; Linio R; Raya M; Vergara S; Juncà J; Grifols JR; Petriz J; Soria MG; Sorigue M
Cytometry B Clin Cytom; 2021 Jul; 100(4):519-530. PubMed ID: 32961011
[TBL] [Abstract][Full Text] [Related]
10. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
[TBL] [Abstract][Full Text] [Related]
11. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
12. Optimization and Validation of an 8-Color Single-Tube Assay for the Sensitive Detection of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia Detected via Flow Cytometry.
Dowling AK; Liptrot SD; O'Brien D; Vandenberghe E
Lab Med; 2016 May; 47(2):103-11. PubMed ID: 27069028
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric assessment of T-cell chronic lymphoproliferative disorders.
Cady FM; Morice WG
Clin Lab Med; 2007 Sep; 27(3):513-32, vi. PubMed ID: 17658405
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.
Aller CT; Kucuk O; Springer GF; Gilman-Sachs A
Am J Hematol; 1996 May; 52(1):29-38. PubMed ID: 8638608
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the brazilian group of flow cytometry (GBCFLUX).
Sales MM; Ferreira SIACP; Ikoma MRV; Sandes AF; Beltrame MP; Bacal NS; Silva MCA; Malvezzi M; Lorand-Metze IGH; Orfao A; Yamamoto M;
Cytometry B Clin Cytom; 2017 Sep; 92(5):398-410. PubMed ID: 27362793
[TBL] [Abstract][Full Text] [Related]
16. Concordance between flow cytometry CLL scores.
Sorigue M; Raya M; Vergara S; Junca J
Int J Lab Hematol; 2021 Aug; 43(4):743-751. PubMed ID: 33949096
[TBL] [Abstract][Full Text] [Related]
17. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
18. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
19. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders.
Pedreira CE; Costa ES; Almeida J; Fernandez C; Quijano S; Flores J; Barrena S; Lecrevisse Q; Van Dongen JJ; Orfao A;
Cytometry A; 2008 Dec; 73A(12):1141-50. PubMed ID: 18836994
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
Porwit A
Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
